Tweet I am not commenting on this you may be interested in the take home message. Bridge F, Sanfilippo PG, Zhu C, Skibina O, Nguyen AL, Kalincik T, Buzzard K, Taylor BV, MacIntyre J, Hall LA, Slee M, Macdonell R, Maltby V, Lechner-Scott J, McCombe P, Butzkueven H, van der Walt A, Jokubaitis VG. Menopause…
ECTRIMS 2025: Frexalimab shows long-term benefits for MS patients
Frexalimab, a therapy Sanofi is developing for multiple sclerosis (MS) patients, led to sustained reductions in disease activity in people with relapsing forms of MS over more than two years […] The post ECTRIMS 2025: Frexalimab shows long-term benefits for MS patients appeared first on Multiple Sclerosis News Today. Source: multiplesclerosisnewstoday.com
ECTRIMS 2025: Ultra-processed foods may fuel disease in early MS
Consuming large amounts of ultra-processed foods (UPF) — products high in additives, artificial ingredients, and extensive processing — is associated with increased disease activity in people with clinically isolated syndrome […] The post ECTRIMS 2025: Ultra-processed foods may fuel disease in early MS appeared first on Multiple Sclerosis News Today. Source: multiplesclerosisnewstoday.com
Amanda Chavez – MSAA’s October 2025 Artist of the Month
MSAA features the work of many talented artists affected by multiple sclerosis as part of our annual MSAA Art Showcase. Each month we share these artists’ inspiring stories and beautiful artwork with you as our Artist of the Month. This month, we celebrate Amanda … Continue reading → Source: blog.mymsaa.org
Q&A October
Tweet Have any questions? Source: multiple-sclerosis-research.org
ECTRIMS 2025: Eque-cel shown to ease disability in progressive MS
Treatment with equecabtagene autoleucel, known for short as eque-cel — Iaso Biotherapeutics‘ CAR T-cell therapy candidate for people with progressive forms of multiple sclerosis (MS) — was well tolerated and […] The post ECTRIMS 2025: Eque-cel shown to ease disability in progressive MS appeared first on Multiple Sclerosis News Today. Source: multiplesclerosisnewstoday.com
ECTRIMS 2025: Drug combo shows promise for myelin repair in trial
Combining the diabetes medication metformin and the antihistamine clemastine significantly increased myelin repair in people with relapsing-remitting multiple sclerosis (RRMS), according to results from a Phase 2 clinical trial. However, […] The post ECTRIMS 2025: Drug combo shows promise for myelin repair in trial appeared first on Multiple Sclerosis News Today. Source: multiplesclerosisnewstoday.com
ECTRIMS 2025: High-dose Vitamin D reduces MS activity, study finds
Increasing blood vitamin D levels with high-dose supplementation can significantly reduce the risk of new disease activity in people with clinically isolated syndrome (CIS), or those who experienced a first […] The post ECTRIMS 2025: High-dose Vitamin D reduces MS activity, study finds appeared first on Multiple Sclerosis News Today. Source: multiplesclerosisnewstoday.com
ECTRIMS 2025: Aerobic exercise may promote myelin repair in MS
Aerobic exercise may help promote myelin repair in some parts of the brain in people with multiple sclerosis (MS), according to a small study. Though the study included a small […] The post ECTRIMS 2025: Aerobic exercise may promote myelin repair in MS appeared first on Multiple Sclerosis News Today. Source: multiplesclerosisnewstoday.com
Prioritizing trips is essential to my plan to travel with MS
I love to travel and have a bucket list of places I want to visit and things I want to see and do in my lifetime. For example, I want […] The post Prioritizing trips is essential to my plan to travel with MS appeared first on Multiple Sclerosis News Today. Source: multiplesclerosisnewstoday.com